Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 228 | 78↓65.5% | 75↓3.8% | 116↑54.1% | 332↑185.7% |
| Gross Profit | 225 | 64↓71.5% | 49↓24.5% | 73↑50.6% | 264↑260.9% |
| Operating Income | -121 | -227↓86.8% | -180↑20.8% | -156↑13.3% | 54↑135.0% |
| Net Income | -144 | -269↓87.5% | -234↑13.2% | -209↑10.4% | -52↑75.3% |
| EBITDA | -120 | -222↓84.6% | -176↑20.6% | -150↑14.9% | 8↑105.0% |
| EPS Diluted | -6.05 | -11.03↓82.3% | -4.33↑60.7% | -2.03↑53.1% | -0.28↑86.2% |